Future research priorities include understanding the long-term effects of senescent cell elimination on tissue homeostasis, regenerative capacity, and overall healthspan, providing foundation for developing sophisticated approaches to aging research and intervention strategies
These same molecules were also subsequently approved for weight lossliraglutide in 2014, and semaglutide, as Wegovy, in 2021
Hiromichi Wakui has received research supports from AstraZeneca, Otsuka Pharmaceutical, and Kaneka Corporation, and honoraria from AstraZeneca, Otsuka Pharmaceutical, Kaneka Corporation, Kyowa Kirin, Sanwa Kagaku, Chugai Pharma, Kowa, Otsuka Pharmaceutical, Novartes, Mitsubishi-Tanabe Pharma, Bayer, and Daiichi-Sankyo Pharma
These drugs were originally designed to support people with type 2 diabetes, helping regulate blood sugar
[Abstract] J Clin Invest